150 related articles for article (PubMed ID: 10846793)
1. Densitometric determination of impurities in pharmaceuticals. Part VI. Determination of 4,4-bis[4-(p-chlorophenyl)- 4-hydroxypiperidino]butyrophenone in haloperidol.
Krzek J; Maślanka A
Acta Pol Pharm; 2000; 57(1):23-6. PubMed ID: 10846793
[TBL] [Abstract][Full Text] [Related]
2. Stability indicating LC method for the determination of pipamperone.
Trabelsi H; Hassen IE; Bouabdallah S; Bouzouita K; Safta F
J Pharm Biomed Anal; 2005 Oct; 39(5):914-9. PubMed ID: 16040223
[TBL] [Abstract][Full Text] [Related]
3. Determination of risperidone in tablets in the presence of its degradation products and placebo-derived constituents.
Maślanka A; Krzek J; Patrzałek A
Acta Pol Pharm; 2009; 66(5):461-70. PubMed ID: 19894641
[TBL] [Abstract][Full Text] [Related]
4. 19F NMR as a powerful technique for the assay of anti-psychotic drug haloperidol in human serum and pharmaceutical formulations.
Shamsipur M; Shafiee-Dastgerdi L; Talebpour Z; Haghgoo S
J Pharm Biomed Anal; 2007 Feb; 43(3):1116-21. PubMed ID: 17084055
[TBL] [Abstract][Full Text] [Related]
5. Quality assessment for tramadol in pharmaceutical preparations with thin layer chromatography and densitometry.
Krzek J; Starek M
Biomed Chromatogr; 2004 Oct; 18(8):589-99. PubMed ID: 15386511
[TBL] [Abstract][Full Text] [Related]
6. Use of chemometrics for development and validation of an RP-HPLC method for simultaneous determination of haloperidol and related compounds.
Petkovska R; Dimitrovska A
Acta Pharm; 2008 Sep; 58(3):243-56. PubMed ID: 19103562
[TBL] [Abstract][Full Text] [Related]
7. Comparative validation of amisulpride determination in pharmaceuticals by several chromatographic, electrophoretic and spectrophotometric methods.
Skibiński R; Komsta Ł; Hopkała H; Suchodolska I
Anal Chim Acta; 2007 May; 590(2):195-202. PubMed ID: 17448345
[TBL] [Abstract][Full Text] [Related]
8. Validation of derivative spectrophotometry method for determination of active ingredients from neuroleptics in pharmaceutical preparations.
Stolarczyk M; Apola A; Krzek J; Sajdak A
Acta Pol Pharm; 2009; 66(4):351-6. PubMed ID: 19702165
[TBL] [Abstract][Full Text] [Related]
9. Quantitative determination of L-DOPA in tablets by high performance thin layer chromatography.
Mennickent S; Nail M; Vega M; de Diego M
J Sep Sci; 2007 Aug; 30(12):1893-8. PubMed ID: 17638351
[TBL] [Abstract][Full Text] [Related]
10. Stability-indicating HPTLC determination of imatinib mesylate in bulk drug and pharmaceutical dosage form.
Vadera N; Subramanian G; Musmade P
J Pharm Biomed Anal; 2007 Jan; 43(2):722-6. PubMed ID: 16920319
[TBL] [Abstract][Full Text] [Related]
11. Quantitative determination of clozapine in serum by instrumental planar chromatography.
Mennickent S; Sobarzo A; Vega M; Godoy CG; de Diego M
J Sep Sci; 2007 Aug; 30(13):2167-72. PubMed ID: 17638358
[TBL] [Abstract][Full Text] [Related]
12. [Polarographic determination of p-fluor substituted butyrophenone derivatives].
Volke J; Wasilewska L; Ryvolová-Kejharová A
Pharmazie; 1971 Jul; 26(7):399-400. PubMed ID: 5094366
[No Abstract] [Full Text] [Related]
13. Quantitative determination of haloperidol in tablets by high performance thin-layer chromatography.
Mennickent S; Pino L; Vega M; Godoy CG; de Diego M
J Sep Sci; 2007 Mar; 30(5):772-7. PubMed ID: 17461119
[TBL] [Abstract][Full Text] [Related]
14. [Thin-layer densitometric determination of clotiazepam in tablets and blood plasma].
Busch M; Ritter W; Möhrle H
Arzneimittelforschung; 1985; 35(2):547-51. PubMed ID: 2859862
[TBL] [Abstract][Full Text] [Related]
15. Determination and degradation study of haloperidol by high performance liquid chromatography.
Trabelsi H; Bouabdallah S; Bouzouita K; Safta F
J Pharm Biomed Anal; 2002 Jul; 29(4):649-57. PubMed ID: 12093494
[TBL] [Abstract][Full Text] [Related]
16. Fluorometric determination of some butyrophenones after permanganate treatment.
Baeyens W; De Moerloose P
Pharmazie; 1977 Dec; 32(12):764-71. PubMed ID: 613315
[TBL] [Abstract][Full Text] [Related]
17. Stability indicating reversed-phase high-performance liquid chromatographic and thin layer densitometric methods for the determination of ziprasidone in bulk powder and in pharmaceutical formulations.
El-Sherif ZA; El-Zeany B; El-Houssini OM; Rashed MS; Aboul-Enein HY
Biomed Chromatogr; 2004 Apr; 18(3):143-9. PubMed ID: 15103698
[TBL] [Abstract][Full Text] [Related]
18. Application of stability-indicating HPTLC method for quantitative determination of metadoxine in pharmaceutical dosage form.
Kaul N; Agrawal H; Patil B; Kakad A; Dhaneshwar SR
Farmaco; 2005 Apr; 60(4):351-60. PubMed ID: 15848212
[TBL] [Abstract][Full Text] [Related]
19. New gradient high-performance liquid chromatography method for determination of donepezil hydrochloride assay and impurities content in oral pharmaceutical formulation.
Kafkala S; Matthaiou S; Alexaki P; Abatzis M; Bartzeliotis A; Katsiabani M
J Chromatogr A; 2008 May; 1189(1-2):392-7. PubMed ID: 18206895
[TBL] [Abstract][Full Text] [Related]
20. Quantitative determination of Piroxicam and its impurities by HPTLC spectrodensitometry.
Quaglia MG; Capitani F; Nocilli F; Grande M
Pharm Acta Helv; 1989; 64(3):86-9. PubMed ID: 2726989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
